News for '-sun-pharma'

Lawsuit filed against Sun Pharma's US arm

Lawsuit filed against Sun Pharma's US arm

Rediff.com23 Jul 2009

A law firm, Izard Nobel LLP, has initiated a lawsuit seeking class action status against the company in the United States District Court for the Eastern District of Michigan on behalf of its investors. The law firm said certain officers and directors of Caraco violated federal securities' laws and interests of the investors by giving misleading information on the business of the company. It has asked the investors to join the suit before September 15 to claim their damages.

Investors lose Rs 2.89 lakh crore in two days of market fall

Investors lose Rs 2.89 lakh crore in two days of market fall

Rediff.com20 Sep 2023

Investors' wealth fell by Rs 2.89 lakh crore in two days of market fall, with the BSE Sensex tumbling 796 points on Wednesday, amid weak global market trends ahead of the US Federal Reserve's interest rate decision. Fresh foreign fund outflows and caution ahead of a host of interest rate decisions from global central banks also added to the overall bearish trend. Besides, the US Fed meeting, the BoE (Bank of England) and the BoJ (Bank of Japan) are also scheduled to meet this week.

Bull run continues; Sensex, Nifty close at record highs

Bull run continues; Sensex, Nifty close at record highs

Rediff.com4 Jul 2023

Benchmark equity indices continued their record-shattering spree on Tuesday, with the Sensex and Nifty hitting their fresh all-time high levels in early trade, amid persistent foreign fund inflows. Also, buying in Bajaj Finance, Bajaj Finserv, Tata Consultancy Services and HDFC twins added to the positive market momentum. Rallying for the fifth straight session, the 30-share BSE Sensex jumped 381.55 points to hit its all-time peak of 65,586.60 in early trade.

Profit might be hit in FY16: Sun Pharma

Profit might be hit in FY16: Sun Pharma

Rediff.com21 Jul 2015

4 Ranbaxy facilities in India have been barred from exporting to US.

Sun Pharma challenges J&J's drug patent

Sun Pharma challenges J&J's drug patent

Rediff.com28 Feb 2008

Mumbai-based Sun Pharmaceuticals has filed a post-grant opposition with the Mumbai patent office against a product patent granted to the extended release version of Johnson and Johnson's (J&J) blockbuster drug Risperdal, used in the treatment of psychological disorders and schizophrenia.

Sun Pharma buys 9% more in Taro

Sun Pharma buys 9% more in Taro

Rediff.com21 Feb 2008

Sun Pharma has increased its stake in Israel's Taro by buying 9.5% more, raising its total holding to 34.4 per cent.

Market moments: RIL, Sun Pharma cheered, Hindalco, NTPC slipped

Market moments: RIL, Sun Pharma cheered, Hindalco, NTPC slipped

Rediff.com15 Jun 2015

While Reliance put up a good show, NTPC nosedived on the BSE on Monday.

Markets rebound over 1%; Sensex ends up 710 points

Markets rebound over 1%; Sensex ends up 710 points

Rediff.com8 May 2023

Among the Sensex firms, IndusInd Bank jumped 5.08 per cent. The other winners were Tata Motors, Bajaj Finance, Bajaj Finserv, NTPC, HCL Technologies, Mahindra & Mahindra, Axis Bank, Maruti and Kotak Mahindra Bank. Value buying in index heavyweights Reliance, HDFC Bank and ICICI Bank added to the momentum. Sun Pharma, Larsen & Toubro and Nestle were the laggards.

Markets extend losses; Sensex tanks 260 points

Markets extend losses; Sensex tanks 260 points

Rediff.com23 Jun 2023

Tata Motors was the biggest loser in the Sensex pack, skidding 1.77 per cent, followed by SBI, Power Grid, Tata Steel, Infosys, UltraTech Cement, Titan, Larsen & Toubro, Reliance Industries and Maruti. On the other hand, IndusInd Bank, Bharti Airtel, Asian Paints, NTPC, HCL Technologies, HDFC and Sun Pharma were the gainers.

Sensex, Nifty rally around 1% on strong macro data

Sensex, Nifty rally around 1% on strong macro data

Rediff.com1 Sep 2023

JSW Steel (3.37 per cent), Tata Steel (3.33 per cent), Maruti (3.24 per cent), Power Grid (3.07 per cent), IndusInd Bank (2.95 per cent), Bajaj Finance (2.12 per cent) and Tech Mahindra (2.22 per cent) were among major gainers. On the other hand, Ultratech Cement, Sun Pharma, Nestle and L&T were the losers.

Eli Lilly sues Sun Pharma over patent

Eli Lilly sues Sun Pharma over patent

Rediff.com2 Apr 2007

Eli Lilly and Company, the US-based multinational pharmaceutical major, has sued Sun Pharmaceuticals in the US, alleging the company infringed its patent on Gemzar, a blockbuster cancer drug.

Sensex slumps 617 pts; Nifty falls below 17,000

Sensex slumps 617 pts; Nifty falls below 17,000

Rediff.com25 Apr 2022

Equity markets opened the trade on a lower note on Monday, extending the previous day's fall, with the Sensex tanking 785 points in early trade, mirroring an extremely weak trend in Asian markets. Also, unabated foreign fund outflows and selling in index majors Reliance Industries, Infosys and TCS added to the weak sentiment. The BSE benchmark Sensex was trading 785 points lower at 56,412.14. The NSE Nifty declined 243.35 points to 16,928.60

Sun Pharma plans buyouts in the US

Sun Pharma plans buyouts in the US

Rediff.com11 Sep 2006

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.

Sensex rises 127 pts, Nifty nears 17k; RIL, Maruti shine

Sensex rises 127 pts, Nifty nears 17k; RIL, Maruti shine

Rediff.com27 Mar 2023

Among the Sensex firms, Reliance Industries, Maruti, Sun Pharma, State Bank of India, UltraTech Cement, Infosys, Kotak Mahindra Bank, Hindustan Unilever, ITC and HDFC Bank were the biggest gainers. Shares of Reliance Industries climbed 1.54 per cent, the most among the 30-share BSE constituents. Power Grid, Axis Bank, Mahindra & Mahindra and Tata Motors were among the major laggards.

Global trends, banking stocks help markets end in green

Global trends, banking stocks help markets end in green

Rediff.com23 Nov 2022

Equity benchmarks ended higher on Wednesday amid buying in banking counters and a firm trend in global markets. Continuing its previous day rally, the 30-share BSE Sensex climbed 91.62 points or 0.15 per cent to settle at 61,510.58. During the day, it jumped 361.94 points or 0.58 per cent to 61,780.90. The broader NSE Nifty gained 23.05 points or 0.13 per cent to end at 18,267.25.

Markets end in red; Sensex down 194 points

Markets end in red; Sensex down 194 points

Rediff.com1 Jun 2023

From the Sensex pack, Bharti Airtel fell 3.42 and Kotak Mahindra Bank declined 3.31 per cent. ICICI Bank, ITC, HDFC Bank, UltraTech Cement, HCL Technologies and Maruti were the other major laggards. Tata Motors, Hindustan Unilever, Asian Paints, Sun Pharma, Nestle, Tata Consultancy Services, Wipro, Bajaj Finance, Axis Bank and IndusInd Bank were among the gainers.

Markets rebound; Sensex, Nifty rally almost 3%

Markets rebound; Sensex, Nifty rally almost 3%

Rediff.com20 May 2022

Equity benchmarks bounced back sharply on Friday after facing a heavy drubbing in the previous trade, with the Sensex and Nifty jumping nearly 3 per cent, aided by positive trends from global markets and across-the-board buying. Index majors Reliance Industries and HDFC twins saw robust buying, helping the benchmarks. The 30-share BSE Sensex rallied 1,534.16 points or 2.91 per cent to settle at 54,326.39.

Power, utility stocks help Sensex, Nifty end in green

Power, utility stocks help Sensex, Nifty end in green

Rediff.com25 Apr 2023

Bajaj Finance led the Sensex gainers' chart, spurting up to 2.38 per cent, followed by Bajaj Finserve rising 2.11 per cent and IndusInd Bank closing 1.66 per cent higher. Bharti Airtel, SBI and L&T increased by 1.60 per cent, 1.28 per cent and 0.92 per cent, respectively.

Markets end in red; Sensex sheds 139 points in volatile trade

Markets end in red; Sensex sheds 139 points in volatile trade

Rediff.com23 Feb 2023

In the Sensex pack, Asian Paints, Larsen & Toubro, Titan, IndusInd Bank, Bharti Airtel, Power Grid, Bajaj Finserv, Infosys, HDFC Bank and HDFC were the major laggards. On the other hand, Axis Bank, Tata Motors, ITC, State Bank of India, Tata Steel and Sun Pharma were among the gainers.

Sensex jumps over 1,000 pts despite Fed rate hike

Sensex jumps over 1,000 pts despite Fed rate hike

Rediff.com17 Mar 2022

Equity benchmark Sensex surged past the 57,000-mark by rallying over 1,000 points on Thursday, tracking an overall bullish trend in global equities despite the US Federal Reserve hiking rates. The 30-share BSE index closed 1,047.28 points or 1.84 per cent higher at 57,863.93. Likewise, the NSE Nifty surged 311.70 points or 1.84 per cent to end at 17,287.05.

Sun Pharma-Ranbaxy deal may come under Sebi lens

Sun Pharma-Ranbaxy deal may come under Sebi lens

Rediff.com9 Apr 2014

Regulator likely to probe possible violation of insider-trading norms.

Sensex surges 600 points to scale 61k-mark

Sensex surges 600 points to scale 61k-mark

Rediff.com14 Feb 2023

ITC topped the Sensex gainers' chart with a jump of 3.31 per cent, followed by Reliance Industries, Bajaj Finance, ICICI Bank, Infosys, Axis Bank and Wipro. On the other hand, NTPC, UltraTech Cement, L&T, Sun Pharma, Asian Paints and Maruti were among the major laggards.

Sensex climbs 375 points amid firm global markets

Sensex climbs 375 points amid firm global markets

Rediff.com1 Nov 2022

Benchmark indices maintained their winning momentum for the fourth day running on Tuesday, helped by a rally in Asian and European markets and continuous foreign fund inflows. The 30-share BSE Sensex climbed 374.76 points or 0.62 per cent to settle at 61,121.35. During the day, it jumped 543.14 points or 0.89 per cent to 61,289.73.

Israel-Hamas conflict: Indian exporters may face higher risk premiums, shipping costs

Israel-Hamas conflict: Indian exporters may face higher risk premiums, shipping costs

Rediff.com8 Oct 2023

Indian exporters shipping goods to Israel may face higher insurance premiums and shipping costs due to the Israel-Hamas conflict, according to experts. Israel witnessed a surprise and unprecedented multifront attack by air, land and sea by the Hamas militant group, which rules the Gaza Strip, in its southern parts on Saturday morning. The International trade experts said the conflict may reduce the profits of domestic exporters but will not impact trade volumes unless war escalates.

Sectors & stocks analysts are betting on post the state poll outcome

Sectors & stocks analysts are betting on post the state poll outcome

Rediff.com13 Dec 2023

The S&P BSE Sensex and the Nifty50 have hit record highs amid the poll outcome-triggered bull frenzy at the bourses. Most analysts feel that the indices are on course to rise further over the next few months - till the general elections - albeit amid intermittent corrections - largely triggered by global developments. Bharatiya Janata Party's (BJP's) win in the three state elections of Madhya Pradesh (MP), Rajasthan and Chhattisgarh, analysts at Jefferies believe, reinforces the consensus expectations of a Modi win 2024 national elections with a greater likelihood of over 300 seats for the BJP.

Sensex rises 123 points to close at five-month high

Sensex rises 123 points to close at five-month high

Rediff.com12 May 2023

Benchmark BSE Sensex recovered from early lows to close at a five-month high on Friday, riding on gains in banking and auto stocks ahead of the release of key inflation data. The 30-share index gained 123.38 points or 0.20 per cent to settle at 62,027.90, the highest closing level since December 12, 2022. The barometer opened lower due to early weakness in energy, power and IT stocks and touched a low of 61,578.15 in the day trade.

Markets fall nearly 1%; Sensex ends down 502 points

Markets fall nearly 1%; Sensex ends down 502 points

Rediff.com2 Mar 2023

From the Sensex pack, Maruti, Axis Bank, Tata Consultancy Services, Nestle, Infosys, Mahindra & Mahindra, Tech Mahindra and Bharti Airtel were the major laggards. Power Grid, Sun Pharma, HCL Technologies, Larsen & Toubro and UltraTech Cement were the gainers.

RIL, ICICI Bank, L&T lift Sensex by 612 points

RIL, ICICI Bank, L&T lift Sensex by 612 points

Rediff.com22 Dec 2021

Bajaj Finance was the top gainer in the Sensex pack, rising around 3 per cent, followed by Bharti Airtel, Sun Pharma, Reliance Industries and SBI. NSE Nifty advanced 184.60 points to 16,955.45.

After two-day selloff, Sensex surges 497 pts at close

After two-day selloff, Sensex surges 497 pts at close

Rediff.com21 Dec 2021

HCL Tech was the top gainer in the Sensex pack, rising around 3 per cent, followed by Tech Mahindra, Tata Steel, Wipro, NTPC and Titan. Nifty advanced 187.05 points to 16,801.25.

Sensex climbs 240 points on buying in index heavyweights

Sensex climbs 240 points on buying in index heavyweights

Rediff.com5 Jun 2023

From the Sensex pack, Mahindra & Mahindra climbed 3.81 per cent and Axis Bank advanced 2.68 per cent, followed by Tata Motors, Larsen & Toubro, Tata Steel, ICICI Bank, Reliance Industries, Maruti, IndusInd Bank and Sun Pharma. Asian Paints, Tech Mahindra, Nestle, Hindustan Unilever, Kotak Mahindra Bank and ITC were among the laggards.

Markets halt 3-day rally; Sensex falls 359 points

Markets halt 3-day rally; Sensex falls 359 points

Rediff.com31 May 2022

Equity benchmarks declined on Tuesday after a three-day rally, with the Sensex falling 359.33 points amid selling in index majors HDFC, Reliance Industries and Infosys. Investors were cautious ahead of release of GDP data, while a jump in crude oil prices also weighed on market sentiment, traders said. The 30-share BSE Sensex went lower by 359.33 points or 0.64 per cent to settle at 55,566.41.

Sensex jumps 350 points following gains in index majors

Sensex jumps 350 points following gains in index majors

Rediff.com29 Mar 2022

Benchmark BSE Sensex rallied over 350 points on Tuesday following gains in index majors HDFC twins, Bharti Airtel and Infosys amid a largely positive trend in global equity markets. The 30-share BSE barometer jumped 350.16 points or 0.61 per cent to settle at 57,943.65. During the day, it rallied 408.04 points or 0.70 per cent to 58,001.53. The broader NSE Nifty gained 103.30 points or 0.60 per cent to settle at 17,325.30.

Sensex ends down 251 points; IT, bank stocks top drags

Sensex ends down 251 points; IT, bank stocks top drags

Rediff.com13 Feb 2023

SBI was the biggest loser in the Sensex pack, tumbling 2.83 per cent, followed by Infosys, TCS, Bajaj Finance, Tech Mahindra, Wipro and Axis Bank. In contrast, Titan, L&T, NTPC, Power Grid, Sun Pharma, ITC and HDFC twins were among the prominent winners, rising as much as 1.97 per cent.

Sensex ends down 208 points on weak global trends

Sensex ends down 208 points on weak global trends

Rediff.com24 May 2023

Among the Sensex firms, Tata Motors, HDFC Bank, ICICI Bank, HDFC, Bajaj Finserv, Reliance Industries, Hindustan Unilever, Larsen & Toubro, Asian Paints and Tata Steel were the major laggards. Sun Pharma, Titan, ITC, IndusInd Bank, Tech Mahindra and Power Grid were among the winners.

Markets halt four-day rally; Sensex ends down 327 points

Markets halt four-day rally; Sensex ends down 327 points

Rediff.com2 Nov 2022

Benchmark indices ended lower on Wednesday after a four-day rally amid a mixed trend in global equity markets. After a positive beginning, the 30-share BSE Sensex failed to hold on to the gains and ended 215.26 points or 0.35 per cent lower at 60,906.09. During the day, it slipped 326.96 points or 0.53 per cent to 60,794.39.

Sun Pharma, Forest settle US suit on Lexapro

Sun Pharma, Forest settle US suit on Lexapro

Rediff.com13 Jul 2009

Sun Pharmaceutical Industries and its subsidiary, Caraco Pharmaceutical Laboratories, have reached a settlement agreement with drugmaker Forest Laboratories and licensing partner H Lundbeck AS, over a pending patent infringement dispute over Forest's blockbuster antidepressant, Lexapro.

Sensex, Nifty end flat in volatile trading

Sensex, Nifty end flat in volatile trading

Rediff.com21 Apr 2023

Among the Sensex firms, ITC, Tata Consultancy Services, Wipro, Asian Paints, HCL Technologies, HDFC, Kotak Mahindra Bank, Bajaj Finance, Infosys, Sun Pharma, Hindustan Unilever, Power Grid, Reliance Industries and HDFC Bank were the winners. HCL Technologies climbed 1 per cent after the company on Thursday posted a 10.85 per cent increase in consolidated net profit to Rs 3,983 crore for the fourth quarter of 2022-23. Tech Mahindra, Maruti, Tata Steel, UltraTech Cement, Tata Motors and ICICI Bank were among the laggards.

Markets pare early gains; Sensex tumbled 635.05 points

Markets pare early gains; Sensex tumbled 635.05 points

Rediff.com21 Dec 2022

Equity benchmarks Sensex and Nifty gave up early gains and ended lower by 1 per cent on Wednesday amid a largely weak trend in Asian markets and sell-off in index majors Reliance Industries, ICICI Bank and HDFC twins. The 30-share BSE benchmark Sensex tumbled 635.05 points or 1.03 per cent to settle at 61,067.24. During the day, it slumped 763.91 points or 1.23 per cent to 60,938.38. The broader NSE Nifty declined 186.20 points or 1.01 per cent to end at 18,199.10.

Sun Pharma gets USFDA nod for anti-cancer injection

Sun Pharma gets USFDA nod for anti-cancer injection

Rediff.com5 Feb 2013

This generic Doxorubicin HCl Liposome injection USP, 2 mg/ml is therapeutically equivalent to Doxil Liposome Injection, 2 mg/ml of Janssen Research and Development, LLC.